Companies: 10,795·Total market cap: $144.5T
EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

EYPTNASDAQHealthcare● Active
$11.78
$-0.48(-3.92%)
Market Cap$987650490
P/E Ratio
52W High$19.11
52W Low$7.94
Overview

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · EYPT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.50eypt eps ttm · eypt earnings per shareEarnings history
PE Ratio (TTM)eypt pe ratio ttm · eypt price to earningsPE Ratio deep dive
Revenue (TTM)$7.6Meypt revenue ttm · eypt annual revenueFull revenue history
Dividend YieldNo Dividenddoes eypt pay dividends · eypt dividend yieldDividend history
Shares Outstanding73.3Meypt shares outstanding · eypt floatShares outstanding history
Next EarningsAug 5, 2026Est.eypt earnings date · eypt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$31.4M▼ 27.50% YoY
202320242025
eyepoint pharmaceuticals, inc. revenue · eypt revenue 2025
FY 2025Net Income-$232.0M▼ 77.25% YoY
202320242025
eyepoint pharmaceuticals, inc. net income · eypt profit 2025
FY 2025EPS$-3.17▼ 36.64% YoY
202320242025
eypt eps · eyepoint pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $7.6MNet Income: -$271.6MEPS: $-3.50View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy18 analystsis eypt a buy · eypt analyst rating
Strong Buy
0
Buy
16
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$36.00Low
$11.78Current
$37.50Avg Target218.34% upside
$39.00High
eypt price target · eypt 12 month forecast

Total: 18 · Buy rate: 88.9%

The EYPT analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $37.50, representing +218.34% upside from the current price of $11.78.

Stock Performance

Full History
1D-3.92%
1W-5.84%
1M-13.76%
3M-25.21%
YTD-35.52%
1Y+31.91%
5Y+29.31%

About EyePoint Pharmaceuticals, Inc.

CEOJay S. Duker
IPO DateJan 27, 2005
Employees165
CountryUS

EyePoint Pharmaceuticals, Inc. a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The com…

what is eyepoint pharmaceuticals, inc. · eypt stock overview · eyepoint pharmaceuticals, inc. company profile · who is eyepoint pharmaceuticals, inc. ceo · eypt NASDAQ · eyepoint pharmaceuticals, inc. headquarters · eyepoint pharmaceuticals, inc. business segments

About Stock Overview & Key Data

EyePoint Pharmaceuticals, Inc. (EYPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 27, 2005. As of the latest trading session, EYPT stock price is $11.78, with a market capitalization of $987.7M. The stock has returned +31.91% over the past 12 months and -35.52% year-to-date.

According to 18 Wall Street analysts, the consensus rating for EyePoint Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $37.50. In fiscal year 2025, EyePoint Pharmaceuticals, Inc. reported revenue of $31.4M and net income of -$232.0M. For detailed data — including EyePoint Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, EyePoint Pharmaceuticals, Inc. (EYPT) stock price is $11.78. The stock is traded on NASDAQ under the ticker symbol EYPT. The 52-week range is $7.94 – $19.11.

EYPT stock priceEYPT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice